In Vivo Disruption of Latent HSV by Designer Endonuclease Therapy

JCI insight - United States
doi 10.1172/jci.insight.88468
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Disruption of Latent HIV in Vivo During the Clearance of Actinic Keratosis by Ingenol Mebutate

JCI insight
Medicine
2019English

TALENs Targeting HBV: Designer Endonuclease Therapies for Viral Infections

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

Unusual Target Site Disruption by the Rare-Cutting HNH Restriction Endonuclease PacI

Structure
Structural BiologyMolecular Biology
2010English

Dissection of Goadsporin Biosynthesis by in Vitro Reconstitution Leading to Designer Analogues Expressed in Vivo

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2017English

Robust Latent-Variable Interpretation of in Vivo Regression Models by Nested Resampling

Scientific Reports
Multidisciplinary
2019English

Designer Peptide Delivery Systems for Gene Therapy

European Journal of Nanomedicine
MedicineBioengineeringTheoretical ChemistryBiomedical EngineeringPhysical
2015English

RNA-guided Endonuclease Provides a Therapeutic Strategy to Cure Latent Herpesviridae Infection

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2014English

Systemic Oncolytic Cytokine HSV Therapy of Prostate Cancer

2007English

Induction of Apoptosis Accelerates Reactivation of Latent HSV-1 in Ganglionic Organ Cultures and Replication in Cell Cultures

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy